Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).
Clinical trial NCT00697216 · COMPLETED
Trial details
- NCT number
- NCT00697216
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1997-03-01
- Primary completion
- 1999-03-01
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.